8-K: Herbalife Reports Net Sales Growth in Fourth Quarter 2023, Initiates Debt Refinancing
Quarterly Report
Herbalife announced year-over-year net sales growth in the fourth quarter of 2023, alongside the initiation of a debt refinancing process.
Summary
- Herbalife reported a 2.9% increase in net sales for the fourth quarter of 2023, reaching $1.2 billion, and a 2.5% increase on a constant currency basis.
- Full-year 2023 net sales were $5.1 billion, a decrease of 2.7% compared to 2022, or a 1.6% decrease on a constant currency basis.
- The company achieved net income of $10.2 million and adjusted EBITDA of $108.8 million for the fourth quarter.
- For the full year, net income was $142.2 million and adjusted EBITDA was $570.6 million.
- Herbalife realized approximately $70 million in cost savings in 2023 from its Transformation Program, with $27 million realized in the fourth quarter.
- The company expects to achieve at least $115 million in run rate savings from the Transformation Program in 2024 and beyond.
- Herbalife is refinancing its 2018 Term Loan A and 2018 Revolving Credit Facility, due in March 2025.
- The company intends to repay $197 million in convertible notes due in March 2024 with available cash and credit facilities.
- Capital expenditures for 2023 were approximately $135 million, and are expected to be between $145 million and $195 million for 2024.
- The new Herbalife.com website is now live in markets representing approximately 70% of the company's sales.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the return to sales growth in Q4 and the success of the Transformation Program, but tempered by the full-year sales decline and ongoing challenges. The company is taking steps to improve its financial position and adapt to market trends.
Positives
- Fourth quarter net sales increased by 2.9% year-over-year, marking the fourth consecutive quarter of improved sales trends.
- The Transformation Program is exceeding initial expectations, with cost savings of $70 million in 2023 and a projected $115 million run rate in 2024.
- The company is actively managing its debt by refinancing existing loans and planning to repay convertible notes.
- The rollout of the new Herbalife.com website is progressing well, covering 70% of sales.
- The company is launching new products to align with consumer trends, including products for those on GLP-1 medications.
- Distributor engagement is improving, with a higher sales leader retention rate compared to the previous year.
Negatives
- Full-year 2023 net sales decreased by 2.7% compared to 2022.
- Gross profit margin for the fourth quarter decreased by 120 basis points year-over-year due to input cost inflation.
- The company recognized pre-tax expenses of approximately $12 million related to the Transformation Program in the fourth quarter and $54 million for the full year.
- Capital expenditures are expected to increase in 2024 to between $145 million and $195 million.
- Net income for the fourth quarter was $10.2 million, down from $54.4 million in the same period last year.
Risks
- The company faces risks related to global economic conditions, including inflation, which could impact sales and supply chains.
- There are risks associated with attracting and retaining members and managing their actions.
- The company is subject to legal and regulatory risks, including challenges to its products and network marketing program.
- The company's international operations are subject to currency fluctuations.
- The refinancing of debt is subject to customary closing conditions and there is no assurance it will occur.
- The company is exposed to risks related to cybersecurity incidents and data breaches.
Future Outlook
The company expects to continue the rollout of its new website, develop new digital capabilities for distributors, and achieve at least $115 million in run rate savings from the Transformation Program in 2024 and beyond. Capital expenditures are expected to be between $145 million and $195 million for the full year of 2024.
Management Comments
- We continue to modernize Herbalife with a sharp focus on top-line growth and margin expansion for 2024, said Michael Johnson, Chairman and CEO.
- We continue to take strategic actions to optimize our cost structure and strengthen our balance sheet, said Alex Amezquita, Chief Financial Officer.
- Our charge is clear sales growth, margin expansion and maximizing shareholder value, said Michael Johnson.
- Together with our distributors, Herbalife is on the path to becoming the global premier health and wellness company, community and platform, said Michael Johnson.
Industry Context
The announcement reflects Herbalife's efforts to adapt to changing market conditions, including a focus on digital transformation and cost optimization, which are common trends in the direct selling and health and wellness industries. The launch of GLP-1 companion products indicates an attempt to capitalize on the growing market for weight loss solutions.
Comparison to Industry Standards
- Herbalife's 2.9% net sales growth in Q4 2023 is a positive sign, but the full-year decline of 2.7% indicates challenges in maintaining consistent growth. Companies like Nu Skin and Amway, also in the direct selling space, have faced similar headwinds, with varying degrees of success in adapting to changing consumer preferences.
- The cost savings achieved through the Transformation Program are significant, and the projected $115 million run rate savings in 2024 is a positive step. This is comparable to other companies in the sector that have implemented restructuring programs to improve efficiency.
- The launch of GLP-1 companion products is a strategic move to tap into the growing weight loss market, similar to how other nutrition companies are adapting to new trends. However, the success of these products will depend on market acceptance and competition.
- Herbalife's digital transformation efforts, including the new website, are in line with industry trends, as companies increasingly rely on digital platforms to reach customers and distributors. The 70% rollout is a good start, but the company needs to ensure the remaining markets are covered effectively.
Stakeholder Impact
- Shareholders may view the Q4 sales growth and cost savings positively, but the full-year decline and increased capital expenditures may raise concerns.
- Distributors may benefit from the new digital tools and increased engagement opportunities.
- Customers may benefit from new product offerings and improved online experience.
- Employees may be impacted by the ongoing Transformation Program and cost optimization efforts.
- Creditors will be impacted by the debt refinancing and repayment of convertible notes.
Next Steps
- Complete the rollout of the new Herbalife.com website to all remaining markets.
- Continue development of digital capabilities for distributors and customers.
- Complete the refinancing of the 2018 Term Loan A and 2018 Revolving Credit Facility.
- Repay the $197 million outstanding principal under the 2024 Convertible Notes.
- Continue to implement the Transformation Program to achieve cost savings.
- Monitor the performance of new product launches, including the GLP-1 Nutrition Companion Product Combos.
Key Dates
| Date | Description |
|---|---|
| February 2, 2024 | Herbalife initiated the refinancing of its 2018 Term Loan A and 2018 Revolving Credit Facility. |
| February 14, 2024 | Herbalife released its fourth quarter and full-year 2023 financial results. |
| March 2024 | Maturity date for the $197 million outstanding principal under the 2024 Convertible Notes. |
| March 2025 | Maturity date for the 2018 Term Loan A and 2018 Revolving Credit Facility. |
| April 25, 2024 | Date of the 2024 Annual General Meeting of Shareholders. |
Keywords
Herbalife, Net Sales, Transformation Program, Debt Refinancing, EBITDA, Cost Savings, GLP-1, Direct Selling, Nutrition, Financial Results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.